EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiologic effects of propranolol in intraventricular conduction disturbance






American Journal of Cardiology 61(4): 341-345

Electrophysiologic effects of propranolol in intraventricular conduction disturbance

Sixteen patients underwent electrophysiologic studies before and after intravenous infusion of propranolol, 0.1 mg/kg. All of them had intraventricular conduction disturbances. A significant (p < 0.01) increase occurred after propranolol in the mean spontaneous cycle length (mean change 122 ms) and the AH interval (mean 28 ms). The HV interval did not change significantly. The effective refractory period of the His-Purkinje system increased in 4 of 5 patients (mean net change 44 ms, p > 0.10). In 7 patients with phase 3 infranodal block, the longest cycle length for producing block increased after propranolol in 5 and remained unchanged in 2 (mean increase 40 ms, p < 0.02). Two patients showed phase 4 atrioventricular block. Propranolol increased the critical cycle length by an average of 120 ms. Propranolol-induced bradycardia restored stable atrioventricular conduction in 2 patients with intermittent 2:1 block but facilitated the occurrence of high grade infranodal block in 1 patient. Thus, propranolol can impair His-Purkinje conduction in patients with preexisting infranodal abnormalities.

Accession: 005349315

PMID: 3341212

DOI: 10.1016/0002-9149(88)90941-1

Download PDF Full Text: Electrophysiologic effects of propranolol in intraventricular conduction disturbance



Related references

Intraventricular conduction disturbance (IVCD), intraventricular aberrant conduction (IVAC). Ryoikibetsu Shokogun Shirizu: 325-328, 1996

The electrophysiologic effects of lidocaine in patients with intraventricular conduction defects. Circulation 49(5): 894-899, 1974

Electrophysiologic effects of magnesium sulfate on intraventricular conduction delay. European Heart Journal 11(ABSTR SUPPL): 240, 1990

Electrophysiologic effects of procaine amide in patients with intraventricular conduction delay. Circulation 49(3): 522-529, 1974

Effects of isoproterenol and propranolol on pharmacologically induced depression of intraventricular conduction. Fundamental & Clinical Pharmacology 3(3): 281-294, 1989

Regional effects of propranolol on intraventricular conduction in coronary artery disease. Clinical Pharmacology and Therapeutics 26(6): 696-700, 1979

Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization. Journal of Cardiovascular Pharmacology 41(6): 870-879, 2003

Non-specific intraventricular conduction disturbance and aberrant ventricular conduction. Nihon Rinsho. Japanese Journal of Clinical Medicine 49(11): 2604-2608, 1991

Atrioventricular and intraventricular conduction disturbances in acute myocardial infarction. Localization of occlusion in relation to the disturbance of conduction illustrated by post-mortem coronary arteriography. Ugeskrift for Laeger 135(10): 522-526, 1973

Electrophysiologic studies on aberrant intraventricular conduction and evaluation of its clinical significance. Zhonghua Nei Ke Za Zhi 23(11): 677-681, 1984